/

EHC

Encompass Health CorporationPre-market

124.42+1.09 +0.88%USD

NYSE · as of Oct 12, 16:00 ET · 20m delay

Open

123.68

Prev close

123.33

Day range

124.02126.36

52-week range

92.77127.99

Volume

1.05M1.16×

Mkt cap

12.27B

P/E ttm

20.81

Fwd P/E

18.63

EPS ttm

5.98

Div yield

0.68%

Earnings

Oct 28, 2026

From 52w high

−2.79%

Price Chart

Yahoo Finance · delayed

EHCOct 12, 2026O 123.68H 126.36L 123.68C 124.42+1.09 (+0.88%)Vol 1.06M

SMA 50121.61
SMA 200108.65

1Y change +1.86% since Oct 10, 2025 close539 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

EHC Encompass Health Corporation · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: +2.85%
1 month: +2.23%
3 months: +13.07%
6 months: +15.67%
Year to date: +17.22%
1 year: +1.86%

Valuation & ownership

Market cap: 12.27B
Enterprise value: 15.87B
P/E (ttm): 20.81
Forward P/E: 18.63
PEG ratio: 0.41
Price / book: 4.73
Price / sales (ttm): 1.98
EV / EBITDA: 10.85
EPS (ttm): 5.98
EPS (forward): 6.68
Beta (5y monthly): 0.60
Dividend yield: 0.68%
Payout ratio: 12.71%
Shares outstanding: 98.65M
Float: 97.65M
Short % of float: 3.99%
Short ratio (days): 4.08
Held by insiders: 0.87%
Held by institutions: 100.86%
Avg volume (3m): 910.58K
50-day average: 121.61
200-day average: 108.65
52-week change: +1.86%
S&P 500 52-week: +17.50%

Technicals (daily)

RSI (14): 57.8
vs 50-day SMA: +2.31%
vs 200-day SMA: +14.52%
50 / 200-day trend: ▲ 50 above 200
MACD vs signal: ▲ above
ATR (14) % of price: 2.35%
Realised vol (20d, ann.): 19.6%
From 52-week high: −2.79%
From 52-week low: +34.12%

ANR

Analyst Consensus

12 analysts

Consensus

Strong buy

1.08 on a 1 (strong buy) – 5 (sell) scale

Mean target

148.17

+19.09% implied

Low 140.00Median 150.00High 155.00

Recommendation trend

Now13 / 0 / 0
1m ago13 / 0 / 0

DES

About Encompass Health Corporation

Yahoo Finance profile

Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.

Sector: Healthcare
Industry: Medical Care Facilities
Employees: 29,699
Headquarters: Birmingham, AL, United States
Website: encompasshealth.com
Officers: Mr. Mark J. Tarr CEO, President & Director
Mr. Douglas E. Coltharp Executive VP & CFO
Mr. Patrick W. Tuer Executive VP & COO

SEAS

Seasonality · EHC

2007–2026 · monthly returns

Strongest month Apr +6.07%Weakest month Oct −2.45%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	-10.9	14.1	-10.3	3.4	5.8	-4.5	9.9	8.2	1.1	2.4			+17.2%
2025	7.5	0.9	1.1	15.5	3.3	1.4	-10.2	10.6	4.3	-10.4	2.1	-8.7	+14.9%
2024	6.5	4.7	11.0	1.0	3.6	-0.7	8.3	0.1	3.9	2.9	3.5	-10.3	+38.4%
2023	4.4	-9.5	-4.3	18.6	-3.3	9.2	-2.5	7.6	-5.5	-6.8	4.2	2.4	+11.6%
2022	-4.9	6.4	7.7	-3.2	-4.8	-14.5	13.5	-4.0	-6.9	20.4	7.4	2.3	+15.2%
2021	-2.8	0.0	1.8	3.6	1.1	-9.0	6.7	-5.8	-4.3	-15.3	-9.3	13.3	−21.1%
2020	11.2	-2.8	-14.4	3.5	10.6	-15.5	9.9	-4.2	-0.4	-5.6	31.4	2.6	+19.4%
2019	8.3	-5.5	-7.5	10.4	-8.6	7.5	0.8	-4.8	4.1	1.2	10.4	-2.0	+12.3%
2018	7.1	0.6	7.3	6.4	6.5	4.6	11.7	7.9	-4.5	-13.7	11.8	-18.0	+24.9%
2017	-5.9	9.0	1.2	9.6	-3.3	6.8	-12.1	7.5	1.3	-0.5	8.3	-1.1	+19.8%
2016	2.8	-1.6	6.8	10.2	-2.7	-3.7	10.9	-5.4	-0.3	-1.0	3.8	-1.0	+18.5%
2015	14.7	-1.5	2.1	1.9	-4.6	6.7	-0.8	-6.6	-10.1	-9.2	1.0	-1.1	−9.5%
2014	-6.6	5.0	9.9	-3.6	1.4	2.1	6.9	2.8	-6.3	9.3	2.0	-6.5	+15.4%
2013	13.0	1.1	9.3	4.3	6.5	-1.7	13.1	-3.4	9.6	1.8	1.9	-6.9	+57.8%
2012	9.2	5.5	0.6	9.3	-14.5	21.5	-3.7	2.2	5.1	-8.0	-0.6	-4.0	+19.5%
2011	9.2	7.0	3.2	2.6	9.5	-6.5	-7.0	-12.3	-30.2	18.3	-2.2	2.3	−14.7%
2010	-4.0	-3.9	8.1	9.4	-2.9	-5.8	-1.1	-12.2	18.1	-5.9	-0.4	15.1	+10.3%
2009	-9.3	-21.0	13.1	5.5	26.4	22.0	-0.3	8.4	0.2	-6.6	20.1	7.0	+71.3%
2008	-19.0	-5.5	10.6	10.6	-4.8	-11.2	-1.3	9.6	2.4	-32.0	-21.5	11.4	−47.8%
2007	3.3	2.6	-12.5	-0.0	-1.1	-12.8	-12.8	15.6	-4.1	14.5	-1.1	5.9	−7.3%

INSD

Insider Activity · EHC

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

49.1K shares

Sells, 6 months

239.4K shares

Net shares

−190.3K

Net change in insider shares

−18.20%

Date	Insider	Transaction	Shares	Value
Aug 30, 2026	Price Andrew L.Officer	Sale at price 120.93 per share.	5.2K	$630.17K
Aug 30, 2026	Darby John PatrickGeneral Counsel	Sale at price 121.09 per share.	4.9K	$588.25K
Aug 30, 2026	Darby John PatrickGeneral Counsel	Conversion of Exercise of derivative security at price 35.06 per share.	4.9K	$170.32K
Aug 9, 2026	Tarr Mark JChief Executive Officer	Sale at price 125.46 - 126.06 per share.	173.1K	$21.72M
Aug 9, 2026	Coltharp Douglas EdwardChief Financial Officer	Sale at price 125.38 per share.	18.9K	$2.37M
Aug 9, 2026	Darby John PatrickGeneral Counsel	Sale at price 125.95 per share.	8.9K	$1.12M
Jul 15, 2026	Reidy Christopher RDirector	Stock Award(Grant) at price 0.00 - 112.40 per share.	340	$35.86K
Jul 15, 2026	Christie Edward M IiiDirector	Stock Award(Grant) at price 0.00 - 112.43 per share.	259	$27.88K
Jul 14, 2026	Herman Joan EDirector	Stock Award(Grant) at price 0.00 per share.	85	—
Jul 14, 2026	Carmichael Gregory DDirector	Stock Award(Grant) at price 0.00 per share.	29	—
Jul 14, 2026	Katz Leslye GDirector	Stock Award(Grant) at price 0.00 per share.	85	—
Jul 14, 2026	Williams TerranceDirector	Stock Award(Grant) at price 0.00 per share.	29	—
Jul 14, 2026	O'Connor Kevin JDirector	Stock Award(Grant) at price 0.00 per share.	19	—
Jul 14, 2026	Hayes Cain A.Director	Stock Award(Grant) at price 0.00 per share.	4	—
Jul 14, 2026	Schlichting Nancy MDirector	Stock Award(Grant) at price 0.00 per share.	40	—
May 14, 2026	Coltharp Douglas EdwardChief Financial Officer	Sale at price 106.83 - 107.28 per share.	27.7K	$2.96M
May 14, 2026	Coltharp Douglas EdwardChief Financial Officer	Conversion of Exercise of derivative security at price 32.94 per share.	27.7K	$912.24K
May 10, 2026	Tuer Patrick WilliamChief Operating Officer	Sale at price 104.56 per share.	682	$71.31K
May 6, 2026	Herman Joan EDirector	Stock Award(Grant) at price 0.00 per share.	1.6K	—
May 6, 2026	Carmichael Gregory DDirector	Stock Award(Grant) at price 0.00 per share.	1.6K	—

CONG

Congress Trades · EHC

House and Senate reports since 2025

Members

0 last bought

Buys

~$16.0K

Sells

~$16.0K

Net

+$0

est. bought − sold

Latest

Oct 31, 25

Lisa McClain

Members who traded it

Member	Buys	Sells	Est. net	Last move
Lisa McClain MI09	2	2	+$0	Sold Oct 31, 25

Bought and sold by quarter (est.)

Members of Congress's EHC trades, newest first
Traded	Member	Owner	Type	Amount	Filed	Report
Oct 31, 25	Lisa McClain MI09	Spouse	Sell	$1,001 - $15,000	Nov 21, 25 (21d)	PDF
Oct 30, 25	Lisa McClain MI09	Spouse	Buy	$1,001 - $15,000	Nov 21, 25 (22d)	PDF
Oct 30, 25	Lisa McClain MI09	Spouse	Sell	$1,001 - $15,000	Nov 21, 25 (22d)	PDF
Jul 22, 25	Lisa McClain MI09	Spouse	Buy	$1,001 - $15,000	Aug 13, 25 (22d)	PDF

From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades

13F

Investors Holding EHC

latest 13F filings of 29 followed managers

Investors holding EHC
Investor	Value	Of portfolio	Shares	Change	Quarter
Renaissance Technologies	$17.6M	0.02%	174.50K	−34%	Q2 2026
Bridgewater Associates · Ray Dalio	$4.1M	0.02%	41.02K	−12%	Q2 2026

From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors

EHC

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

EHC

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About Encompass Health Corporation

Seasonality · EHC

Insider Activity · EHC

Congress Trades · EHC

Members who traded it

Bought and sold by quarter (est.)

Investors Holding EHC

Investors Holding EHC

Congress Trades · EHC

Members who traded it

Bought and sold by quarter (est.)

Seasonality · EHC

Insider Activity · EHC

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About Encompass Health Corporation

Financial Snapshot

Earnings & Dividends

News